Publikationen

Integration of tumor mutation burden and PD-L1 testing in routine laboratory diagnostics in non-small cell lung cancer

Stefanie Schatz *, Markus Falk, Balázs Jóri, Oum el Kheir Ramdani Hayat, Stefanie Schmidt, Eva-Maria Willing, Roopika Menon, Harry Groen, Linda Diehl, Matthias Kröger, Claas Wesseler, Frank Griesinger, Petra Hoffknecht, Markus Tiemann, Lukas Heukamp *

(submitted)

High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses.

Metzelder SK, Schroeder T, Finck A, Scholl S, Fey M, Götze K, Linn YC, Kröger M, Reiter A, Salih HR, Heinicke T, Stuhlmann R, Müller L, Giagounidis A, Meyer RG, Brugger W, Vöhringer M, Dreger P, Mori M, Basara N, Schäfer-Eckart K, Schultheis B, Baldus C, Neubauer A, Burchert A.

Leukemia. 2012 Nov;26(11):2353-9. doi: 10.1038/leu.2012.105. Epub 2012 Apr 16.

Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.

Stelljes M, Bornhauser M, Kroger M, Beyer J, Sauerland MC, Heinecke A, Berning B, Scheffold C, Silling G, Buchner T, Neubauer A, Fauser AA, Ehninger G, Berdel WE, Kienast J; Cooperative German Transplant Study Group.

Blood. 2005 Nov 1;106(9):3314-21. Epub 2005 Jul 14.

Prediction of relapse of acute myeloid leukemia in allogeneic transplant recipients by marrow CD34+ donor cell chimerism analysis.

Scheffold C, Kroeger M, Zuehlsdorf M, Tchinda J, Silling G, Bisping G, Stelljes M, Buechner T, Berdel WE, Kienast J.

Leukemia. 2004 Dec;18(12):2048-50. No abstract available.

Transplantation strategies in AML: AMLCG data.

Kienast J, Stelljes M, Berning B, Kröger M, Sauerland MC, Heinecke A, Schoch C, Wörmann B, Büchner T, Hiddemann W, Berdel WE; German AML Cooperative Group.

Ann Hematol. 2004;83 Suppl 1:S136-7.

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor.

Sayer HG, Kröger M, Beyer J, Kiehl M, Klein SA, Schaefer-Eckart K, Schwerdtfeger R, Siegert W, Runde V, Theuser C, Martin H, Schetelig J, Beelen DW, Fauser A, Kienast J, Höffken K, Ehninger G, Bornhäuser M; Cooperative German Transplant Study Group.

Bone Marrow Transplant. 2003 Jun;31(12):1089-95.

Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma.

Bisping G, Leo R, Wenning D, Dankbar B, Padró T, Kropff M, Scheffold C, Kröger M, Mesters RM, Berdel WE, Kienast J.

Blood. 2003 Apr 1;101(7):2775-83. Epub 2002 Nov 27.

Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients.

Kiehl MG, Schäfer-Eckart K, Kröger M, Bornhäuser M, Basara N, Blau IW, Kienast J, Fauser AA, Ehninger G, Armstrong VW, Shipkova M.

Transplant Proc. 2002 Nov;34(7):2922-4. No abstract available.

Life quality of patients with metastatic renal cell carcinoma and chemo-immunotherapy–a pilot study.

Kröger MJ, Menzel T, Gschwend JE, Bergmann L.

Anticancer Res. 1999 Mar-Apr;19(2C):1553-5.